Sun Pharma Dermatology Deal History & Licensing Activity
Sun Pharma Dermatology is a large pharma headquartered in India. The company currently has 5 active clinical trials, primarily in Solid Tumors.
Deals (12mo)
2
Active Trials
5
Top Modality
N/A
Focus Area
Solid Tumors
Sun Pharma Dermatology Pipeline Focus
Therapeutic areas and modalities where Sun Pharma Dermatology is most active based on deal history and clinical trial data.
Therapeutic Areas
Sun Pharma Dermatology Strategic Signals
Key indicators of Sun Pharma Dermatology's licensing and acquisition strategy, including patent expirations, pipeline gaps, and strategic priorities.
Strategic Profile
Acquisition Appetite
Strategic Priorities
Sun Pharma Dermatology Clinical Pipeline
Sun Pharma Dermatology has 5 active clinical trials across 2 development phases.
2
Phase 1
3
Phase 2
See How Your Asset Matches Sun Pharma Dermatology's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Solid Tumors assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
About Sun Pharma Dermatology Licensing & Deal Activity
Sun Pharma Dermatology is a large pharma company based in India that has been actively engaged in licensing transactions across the biopharma landscape.
Key therapeutic areas of focus for Sun Pharma Dermatology include Solid Tumors (1 deal and trial), CNS Disorders (1 deal and trial), and Hematological Malignancies (1 deal and trial).
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Sun Pharma Dermatology and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Sun Pharma Dermatology's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.